4175tr human triple negative breast cancer cells (ATCC)
Structured Review

4175tr Human Triple Negative Breast Cancer Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 27290 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/4175tr human triple negative breast cancer cells/product/ATCC
Average 99 stars, based on 27290 article reviews
Images
1) Product Images from "DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity"
Article Title: DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Journal: Nature Communications
doi: 10.1038/ncomms15618
Figure Legend Snippet: ( a , b ) Trex1 expression and cytoplasmic dsDNA accumulations in MDA-MB-231 ( a ) and 4175TR ( b ) breast carcinoma cells 24 hrs after in vitro treatment. Duplicate; * P <0.05; ** P <0.005; *** P <0.0005: t -test; n =3. All data are mean±s.e.m. ( c ) Trex1 , Ifnb1 and Mx1 expression measured by qRT-PCR in a patient-derived tumour xenograft (PDTX) 24 h after mice treatment with tumour-directed radiation. Duplicate; * P <0.05; ** P <0.005; *** P <0.0005: t -test; n =4. All data are mean±s.e.m.
Techniques Used: Expressing, In Vitro, Quantitative RT-PCR, Derivative Assay